Page last updated: 2024-12-07
indenestrol b
Indenestrol b is a non-steroidal synthetic estrogen. It was first synthesized in 1951 and was initially marketed as a treatment for menopausal symptoms. However, it was withdrawn from the market due to concerns about its safety. Indenestrol b has been shown to have estrogenic activity in animal studies, but its effects in humans are not well understood. The compound is currently being studied for its potential therapeutic uses, such as in the treatment of breast cancer. It is being investigated for its potential as a selective estrogen receptor modulator (SERM). SERMs are a class of drugs that can act as agonists or antagonists of estrogen receptors, depending on the target tissue. Indenestrol b is also being studied for its potential to prevent osteoporosis.'
Cross-References
ID Source | ID |
PubMed CID | 114716 |
MeSH ID | M0137158 |
Synonyms (15)
Synonym |
indenestrol b |
1h-inden-5-ol, 1-ethyl-2-(4-hydroxyphenyl)-3-methyl- |
ccris 7205 |
1-ethyl-2-(4-hydroxyphenyl)-3-methyl-1h-inden-5-ol |
indenoestrol b |
38028-27-2 |
133830-97-4 |
unii-jhx6qh0hf6 |
jhx6qh0hf6 , |
(+/-)-indenestrol b |
indenestrol b, (+/-)- |
(rs)-indenestrol b |
1-ethyl-2-(4-hydroxyphenyl)-3-methylinden-5-ol |
Q27281510 |
DTXSID301030716 |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.05
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.05 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.99 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |